SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
SBFM stock results show that Sunshine Biopharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
The post SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace